[1]
L. M. . Cedillo, J. D. Velázquez López, E. C. . Bonilla, R. H. . Hernández, and S. G. . Jessica, “BRAF Wild-Type Melanomas with NF1 Mutations: Implications for MEK Inhibitor Therapy in Specific Molecular Subgroups”, International Journal Of Medical Science And Clinical Research Studies, vol. 5, no. 09, pp. 1610–1614, Sep. 2025.